• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Albany Molecular Research Inc

+ Add to Watchlist


11.614 EUR 0.102 0.89%

As of 10:45:50 ET on 04/17/2014.

Snapshot for Albany Molecular Research Inc (AYM)

Open: 11.390 Day's Range: 11.390 - 11.614 Volume: 0
Previous Close: 11.512 52wk Range: 6.928 - 14.480 1-Yr Rtn: +66.87%

Stock Chart for AYM

No chart data available.
  • AYM:GR 11.614
  • 1D
  • 1M
  • 1Y
Interactive AYM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AYM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 20.4451
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.7850
Est. PEG Ratio -
Market Cap (M EUR) 375.45
Shares Outstanding (M) 32.33
30 Day Average Volume 26
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AYM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AYM

Albany Molecular Research, Inc., an integrated chemistry outsourcing company, offers a variety of chemistry research and development services. The Company provides its services to pharmaceutical and biotechnology companies involved in drug discovery and development. Albany offers medicinal chemistry, chemical development, analytical chemistry services, and small-scale manufacturing.

William S Marth "Bill"President/CEOMichael A Luther "Mike"Senior VP:Discovery
Steven R HagenSenior VP:PharmaceuticalGeorge SvokosSenior VP:Sales
More Company Profile & Key Executives for AYM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil